Streetbeat News

Equity Actions

FFIV

NRIM

NUE

SMCI

WHR

Investors are watching Super Micro Computer, Northrim BanCorp, Nucor Corporation, F5, Inc., and Whirlpool Corporation as they head into Monday with mixed U.S. stock futures. Super Micro Computer is expected to report earnings of $4.93 per share on $3.06 billion revenue, Northrim BanCorp authorized additional stock repurchase, Nucor is anticipated to earn $2.87 per share on $7.65 billion revenue, F5 is projected to report earnings of $3.04 per share on $685.34 million revenue, and Whirlpool is expected to post earnings of $3.56 per share on $4.98 billion revenue.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 9:12 am

HLNE

Hamilton Lane (NASDAQ:HLNE), a private markets investment management firm, has expanded its global Real Assets Investments Team by hiring Managing Director Dominik von Scheven in Frankfurt and Principal Taylor McManus in Canada. Both will focus on infrastructure investing and report to Brent Burnett. von Scheven, with over two decades of experience, will play a key role in European infrastructure equity investments and continue to grow the firm's Infrastructure Investments platform, which has increased by 35% to $57.6 billion in AUM over the last two years.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 8:12 am

SUBL

Amer Sports, Inc (NYSE:AS) and BIOLINGUS (CAYMAN) LIMITED (NASDAQ:SUBL) are set to go public on Feb. 1, 2024, and Jan. 31, 2024, respectively. Amer Sports will offer 100 million shares at $17.00 each, while BIOLINGUS will offer 360,000 shares at $15.50 each. Both companies have a 180-day insider lock-up period post-IPO.

Portfolio Pulse from Benzinga Insights

January 28, 2024 | 5:03 pm

BRK-A

COST

Warren Buffett's Berkshire Hathaway Inc. sold its shares in Costco Wholesale Corporation in 2020, missing out on approximately $1.5 billion in gains as Costco's stock soared up to 127% since the sale. Berkshire Hathaway began investing in Costco in 1999, accumulating 4.3 million shares by mid-2020. Buffett has acknowledged the sale as a potential mistake during Berkshire's 2021 shareholder meeting.

Portfolio Pulse from Bibhu Pattnaik

January 27, 2024 | 9:20 pm

ARKK

ARKW

TSLA

Cathie Wood's Ark Invest purchased $66 million worth of Tesla shares after the company's stock slumped following a Q4 earnings miss. Ark's ETFs, ARKK and ARKW, bought 182,541 and 177,870 Tesla shares respectively. Despite Tesla's recent downtrend and a double miss in Q4 earnings, Wood remains bullish on Tesla, projecting a $2,000 stock price by 2027, largely based on the potential of its robotaxi service. Tesla is a major holding in both ARKK and ARKW, which saw a slight increase in their share price.

Portfolio Pulse from Shanthi Rexaline

January 27, 2024 | 7:23 pm

CMPS

GHRS

IXHL

PSIL

A new study suggests suggestibility plays a role in the antidepressant effects of psilocybin therapy. The EU has allocated $7M for psychedelic research for various disorders. In Australia, the first psychedelic-assisted medical treatments in 50 years were provided. Incannex Healthcare's CEO discussed the company's role in psychedelic-assisted therapies on the Benzinga Psychedelics Podcast. Psychedelics stocks showed varied performance, with COMPASS Pathways, GH Research, and Incannex Healthcare closing higher, while others like Seelos Therapeutics and Enveric Biosciences closed lower. The AdvisorShares Psychedelics ETF (PSIL) closed at $1.43.

Portfolio Pulse from Lara Goldstein

January 27, 2024 | 3:00 pm

NVDA

Billionaire investor Jeffrey Gundlach warns of an inevitable recession and advises investors to hold cash over overvalued stocks. He expresses skepticism about current market valuations, particularly the S&P 500 and tech stocks like Nvidia Corp. (NVDA), which have seen significant increases. Gundlach cites the inverted yield curve and the Leading Economic Index's downward trend as indicators of a looming recession and suggests the Federal Reserve should cut interest rates.

Portfolio Pulse from Rounak Jain

January 27, 2024 | 7:09 am

NRIM

Northrim (NRIM) has announced authorization for the repurchase of up to an additional 110,000 shares of its common stock. This move indicates the company's confidence in its financial stability and a commitment to delivering shareholder value. The repurchase program may also signal management's belief that the stock is undervalued.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 9:17 pm

CBST

GTBIF

JUSHF

Virginia is progressing towards a regulated cannabis market with the Senate Subcommittee on Cannabis approving Senate Bill 448, aiming to create an equitable marketplace. The bill, merged with SB 423, seeks to avoid preferential treatment for medical marijuana companies. Existing medical cannabis companies like The Cannabist Company Holdings Inc. (CBST), Green Thumb Industries Inc. (GTBIF), and Jushi Holdings Inc. (JUSHF) are expected to have an early advantage. The market is projected to be limited in competition initially, with 300+ retail licenses planned. Social equity is a focus, with a 6% excise tax funding related initiatives. A timeline for the market's development has been set, with recreational sales by medical incumbents starting July 1, 2024. Roanoke College is launching a Cannabis Studies Program in fall 2024.

Portfolio Pulse from Nicolás Jose Rodriguez

January 26, 2024 | 9:07 pm

PALI

Palisade Bio has filed a request with the SEC to withdraw its registration statement, indicating a potential shift towards private offerings. The company also asked for fees paid to the SEC to be credited for future filings.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 9:07 pm